Active, not recruitingNCT04687358
REgiStry Of the NAtural History of recurreNt periCarditis in pEdiatric and Adult Patients
Studying NON RARE IN EUROPE: Pericarditis
Last synced from ClinicalTrials.gov
ℹ
Clinical trial records are synced from ClinicalTrials.gov through automated extraction.
Report missing dataKey facts
- Sponsor
- Kiniksa Pharmaceuticals International, plc
- Principal Investigator
- John F Paolini, MD, PhDKiniksa Pharmaceuticals Corp
- Enrollment
- 500 target
- Eligibility
- 7 years · All sexes
- Timeline
- 2021 – 2029
Study locations (29)
- Alaska Heart & Vascular Institute, Anchorage, Alaska, United States
- Pima Heart and Vascular, Tucson, Arizona, United States
- University of California San Diego Medical Center, La Jolla, California, United States
- Cedars-Sinai Medical Center, Los Angeles, California, United States
- Scripps Health, San Diego, California, United States
- Northwestern University, Chicago, Illinois, United States
- Midwest Cardiovascular Research Foundation, Davenport, Iowa, United States
- Johns Hopkins University, Baltimore, Maryland, United States
- Massachusetts General Hospital, Boston, Massachusetts, United States
- Brigham and Women's Hospital, Boston, Massachusetts, United States
- Detroit Medical Center, Detroit, Michigan, United States
- Minneapolis Heart Institute Foundation, Minneapolis, Minnesota, United States
- Mayo Clinic - PPDS, Rochester, Minnesota, United States
- Barnes-Jewish Hospital/Washington University, St Louis, Missouri, United States
- University of Nebraska, Omaha, Nebraska, United States
- +14 more locations on ClinicalTrials.gov
Collaborators
Kiniksa Pharmaceuticals (UK), Ltd.
Primary source
Recruitment status, site addresses, contacts, and full eligibility criteria can change between syncs. Always verify with the trial team before planning travel or treatment.
Open NCT04687358 on ClinicalTrials.gov